AstraZeneca PLC (AZN) vs Gilead Sciences, Inc. (GILD)
A side-by-side comparison of AstraZeneca PLC and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
AZN
AstraZeneca PLC
$172.74HealthcareDelayed quote: Jul 29, 2026, 3:35 PM EDT
GILD
Gilead Sciences, Inc.
$133.27HealthcareDelayed quote: Jul 29, 2026, 3:35 PM EDT
Total return — AZN vs GILD
growth of $100 · dividends reinvested · last 30yAZN +2065.6%GILD +33309.9%GILD compounded faster
Log scale — wide-divergence pair
AZN GILD
AZN vs GILD: by the numbers
- •GILD is the larger company ($165.46B vs $133.87B market cap).
- •AZN trades at the lower trailing earnings multiple (12.99 vs 18.30 P/E), one valuation lens rather than an overall verdict.
- •GILD converts more revenue to profit (30.99% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 3.07% CAGR).
- •GILD pays the higher dividend yield (2.40% vs 1.86%).
Metrics side by side
Valuation
| Metric | AZN | GILD |
|---|---|---|
| P/E ratio | 12.99 | 18.30 |
| Forward P/E | 16.82 | N/A |
| P/S ratio | 2.23 | 5.66 |
| P/B ratio | 2.84 | 7.16 |
| PEG ratio | 0.29 | 0.01 |
| EV / EBITDA | 8.00 | 12.95 |
| FCF yield | 6.00% | 6.07% |
Profitability
| Metric | AZN | GILD |
|---|---|---|
| Gross margin | 81.68% | 79.35% |
| Operating margin | 23.69% | 38.26% |
| Net margin | 17.19% | 30.99% |
| ROE | 21.95% | 39.19% |
| ROIC | 13.03% | 21.53% |
Dividends
| Metric | AZN | GILD |
|---|---|---|
| Dividend yield | 1.86% | 2.40% |
| Payout ratio | 24.24% | 47.08% |
Growth (annualized)
| Metric | AZN | GILD |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 3.07% |
| EPS CAGR (5Y) | 22.02% | 133.83% |
| FCF CAGR (5Y) | 15.68% | 3.30% |
| Total return CAGR (5Y) | 10.67% | 18.12% |
Frequently asked
- Which has the lower trailing P/E, AZN or GILD?
- AZN has the lower trailing P/E: AZN trades at 12.99 and GILD at 18.30. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AZN or GILD?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus GILD at 3.07%.
- Does AZN or GILD pay a bigger dividend?
- AZN yields 1.86% and GILD yields 2.40% based on trailing dividends and the latest price.
- Is AZN or GILD more profitable?
- GILD runs the higher net margin — AZN at 17.19% versus GILD at 30.99%.
- How have AZN and GILD total returns compared?
- Over the past 10 years, AZN delivered 13.18% and GILD delivered 8.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioGilead Sciences P/E ratioAstraZeneca dividend yieldGilead Sciences dividend yieldAstraZeneca ROEGilead Sciences ROEAstraZeneca operating marginGilead Sciences operating marginAstraZeneca revenue growthGilead Sciences revenue growthAstraZeneca free cash flowGilead Sciences free cash flow
AstraZeneca & Gilead Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.